Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
- 1 January 2002
- journal article
- clinical trial
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 42 (1) , 21-27
- https://doi.org/10.1046/j.1526-4610.2002.02009.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Triptans in MigraineDrugs, 2000
- Guidelines for Controlled Trials of Drugs in Migraine: Second EditionCephalalgia, 2000
- Tolerability of sumatriptan: clinical trials and post-marketing experienceCephalalgia, 2000
- Acute Migraine Therapy: Do Doctors Understand What Patients With Migraine Want From Therapy?Headache: The Journal of Head and Face Pain, 1999
- Pharmacology of triptansEmerging Drugs, 1999
- Zolmitriptan, a 5‐HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose‐range finding studyEuropean Journal of Neurology, 1998
- Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo‐Controlled, Outpatient StudyHeadache: The Journal of Head and Face Pain, 1998
- Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraineTrends in Pharmacological Sciences, 1992
- Methodology of Clinical Trials of Sumatriptan in Migraine and Cluster HeadacheEuropean Neurology, 1991
- 5-HT1-like receptor agonists and the pathophysiology of migraineTrends in Pharmacological Sciences, 1989